Researchers propose new vision of process wrongly associated with ageing

July 14, 2014

For the Spanish Royal Academy, senescent is he who "begins to age". But laboratory biology results are contradicting the dictionary: not only is senescence not a synonym of ageing, it is also not intrinsically negative for the organism. Cellular senescence is such a badly named physiological process that those who do research in this area think it needs another name. That is the case of Manuel Serrano, from the Spanish National Cancer Research Centre (CNIO), one of the world's leading experts on senescence, who has just published a review on this topic. Without actually renaming senescence, this edition of Nature Reviews promotes a paradigm shift: senescence is, above all, "a mechanism to eliminate unwanted cells", which ends with the remodelling of tissues. And it can be something of a double-edged sword for the body.

More than five decades ago, Leonard Hayflick and Paul Moorhead discovered that healthy human cells growing in culture stop proliferating after a certain number of divisions. They called the phenomenon cellular senescence and postulated that it could be the cause of ageing in the body. But more recent research, led largely by Serrano and his group—Daniel Muñoz-Espín is co-author of the current revision—has shown that this pioneering observation only told part of the story.

Today, we know that the relationship between senescence and ageing resembles that between firemen and fire: although there are many firemen at a fire, they are not the cause of the blaze but rather an attempt to put it out. In a similar way, Serrano and Muñoz-Espín propose that senescence activates when there is damage to a cell, to prevent it from spreading or even to repair the affected tissue. In ageing organisms, what happens is that the process stops halfway with a large number of present in the tissues.

The authors talk of a sequence of events: "Senescence-clearance-regeneration". "Recent discoveries are redefining our vision of ", they write. To achieve their goal: "senescent cells inhibit their own proliferation, induce their own elimination by attracting cells from the immune system and finally promote tissue regeneration". In aged tissues or with certain diseases, however: "this sequence is not completed, and the senescent cells accumulate".

That is why: "senescence can become part of the problem with ageing, instead of the solution", write the authors.

Today it is known that cells initiate their senescence programme in response to stimulants such as the activation of different oncogenes—cancer-causing genes; the absence or malfunction of anti-cancer genes; or the shortening of telomeres, the protein structures that protect the ends of chromosomes. All of these stimulants damage cells and senescence then works as a protective mechanism.

Furthermore, Serrano and Muñoz-Espín have recently discovered that senescence intervenes in another key process for the organism, in a stage very far removed from ageing: development. As the embryo grows, it needs to get rid of or redesign physiological structures, and the genetic orders it uses to that end are those related to senescence.

This discovery has allowed these researchers to complete their vision of senescence as a mechanism that is really there to: "eliminate unwanted cells" and end up regenerating tissue, even with a different than the one it had previously.

In this new vision, therefore, senescence is just a physiological mechanism. The question is: should we stimulate it, to fight cancer, for example, or should we prevent it, to stop ageing? Both, say the researchers.

The revision presents a list of pathologies in which senescence can have either a beneficial or harmful effect. In several types of cancer, for example, senescence stops the advance of the disease; in cardiovascular disease, it restricts atheroma formation; it is also beneficial against several types of fibrosis. With obesity and diabetes, however, it favours disease development, increasing resistance to insulin and inflammation.

Clinical research also reflects the two faces of senescence, given that both therapies based on promoting it—specifically against cancer and kidney and liver fibrosis—and on stopping it are being studied. The authors underline the success in breast cancer trials of a new drug that stimulates senescence: palbociclib.

But they leave one mystery unsolved: moles. Nowadays we know that moles are collections of senescent cells that have not been eliminated. Why? To be continued.

Explore further: Study discovers that senescence also plays a role in embryo development

More information: Cellular senescence: from physiology to pathology. Muñoz-Espín D, Serrano M. Nature Reviews Molecular Cell Biology (2014). DOI: 10.1038/nrm3823

Related Stories

Study discovers that senescence also plays a role in embryo development

November 14, 2013
One of the main mechanisms the body uses to protect itself against cancer is to switch off defective cells by making them senescent; these cells do not die but stop dividing: their life cycle stops. A team of researchers ...

Tipping the balance between senescence and proliferation

November 15, 2013
An arrest in cell proliferation, also referred to as cellular senescence, occurs as a natural result of aging and in response to cellular stress. Senescent cells accumulate with age and are associated with many aging phenotypes, ...

Cell senescence does not stop tumor growth

January 19, 2012
Since cancer cells grow indefinitely, it is commonly believed that senescence could act as a barrier against tumor growth and potentially be used as a way to treat cancer. A collaboration between a cancer biologist from the ...

Study discovers that stem cell senescence drives aging

April 18, 2013
Declining levels of the protein BubR1 occur when both people and animals age, and contribute to cell senescence or deterioration, weight loss, muscle wasting and cataracts. Mayo Clinic researchers have shown that adult progenitor ...

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

Omega-3 fatty acids fight inflammation via cannabinoids

July 18, 2017
Chemical compounds called cannabinoids are found in marijuana and also are produced naturally in the body from omega-3 fatty acids. A well-known cannabinoid in marijuana, tetrahydrocannabinol, is responsible for some of its ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.